3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
5
Genitourinary
4
Breast
4
Gynecologic
3
Tumor-Agnostic
2
Sarcoma
2
Myeloid
2
Lymphoid
2
Head & Neck
2
Thoracic
1
Plasma cell
1
Other hematologic neoplasm
1
Dermatologic
1
Classical hematology
1
CNS
1
Conditions
Melanoma
12
Lymphoma, T-Cell, Cutaneous
5
Mycosis Fungoides
4
Sezary Syndrome
3
Lung Neoplasms
3
Endometrial Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Uveal Melanoma
2
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Ovarian Neoplasms
2
Multiple Myeloma
2
Lymphoma, T-Cell
2
Carcinoma, Renal Cell
2
Carcinoma, Merkel Cell
2
Carcinoma, Hepatocellular
2
Uterine Neoplasms
1
Urogenital Neoplasms
1
Urethral Neoplasms
1
Ureteral Neoplasms
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Skin Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Neoplasm Metastasis
1
Interventions
pembrolizumab
36
Cyclophosphamide
24
Nivolumab
23
Ipilimumab
22
aldesleukin
19
Interleukin-2
15
fludarabine
14
Specimen Handling
12
Dacarbazine
11
fludarabine phosphate
10
Magnetic Resonance Spectroscopy
10
Temozolomide
9
Radiosurgery
9
Biopsy
9
cemiplimab
8
Paclitaxel
8
dabrafenib
5
binimetinib
5
Vemurafenib
5
Radiotherapy
5
Carboplatin
5
trametinib
4
sargramostim
4
encorafenib
4
avelumab
4
Pemetrexed
4
Leucovorin
4
Fluorouracil
4
Cisplatin
4
Bevacizumab
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasm Metastasis
×
Immunoglobulin G
×
Dermatologic
×
Clear all
NCT05269381
2026-03-12
PNeoVCA
Mayo Clinic
Phase 1/2
Recruiting
132 enrolled